Differentiation of stable kidney function versus progressive dysfunction in dogs

Differentiation of stable kidney function versus progressive dysfunction in dogs

Abstract Background Circulating creatinine and symmetric dimethylarginine (SDMA) are biomarkers of kidney function that have been used variously to define stable vs progressive chronic kidney disease (CKD). Slope monitoring of inverse biomarker values (creatinine−1 or SDMA−1) has shown promise, but...

Full description

Bibliographic Details
Main Authors:	Larry D. Cowgill, Gilad Segev, Shelly Vaden, Sheri Ross, Cedric Dufayet, Leah A. Cohn, Mary Nabity, Giosi Farace, Donald Szlosek, Zenhwa Ouyang, Sarah Peterson, Melissa Beall, Murthy Yerramilli, David Polzin
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Series:	Journal of Veterinary Internal Medicine
Subjects:	biomarker creatinine disease monitoring inverse slope symmetric dimethylarginine
Online Access:	https://doi.org/10.1111/jvim.16885

Similar Items

Urinary cystatin B differentiates progressive versus stable IRIS Stage 1 chronic kidney disease in dogs
by: Gilad Segev, et al.
Published: (2023-11-01)

Short‐term evaluation of renal markers in overweight adult cats
by: Laura Pérez‐López, et al.
Published: (2023-03-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs
by: M.A. Kopke, et al.
Published: (2018-03-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

Alterations of Serum Biochemical and Urinary Parameters in a Canine Population before and after Intravenous Contrast Administration
by: Federica Cagnasso, et al.
Published: (2021-07-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
by: Joanna Piechowicz, et al.
Published: (2022-08-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

Is symmetric dimethylarginine superior to creatinine for assessing glomerular filtration rate for cats with kidney disease?
by: Lorna Hardy
Published: (2023-10-01)

Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
by: Iwona Bednarz-Misa, et al.
Published: (2020-08-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

Symmetric Dimethylarginine is a Promising Biomarker for the Early Detection of Age-Related Kidney Dysfunction in Zoo Felids
by: Youn Soong-Hee, et al.
Published: (2022-09-01)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-09-01)

Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis
by: Kuo-Hsuan Chang, et al.
Published: (2021-12-01)

Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications
by: Linfeng Chen, et al.
Published: (2023-09-01)

ADMA, SDMA and L-arginine may be novel targets in pharmacotherapy for complications due to cardiopulmonary bypass
by: Kahraman Aydin, et al.
Published: (2017-01-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

The role of L-arginine in the pathogenesis of essential arterial hypertension
by: V. A. Shcherbak, et al.
Published: (2024-03-01)

Evaluation of renal values during treatment for heartworm disease in 27 client-owned dogs
by: C. Autumn M. Vetter, et al.
Published: (2023-06-01)

Utilizing liposomal encapsulation approach to address nephrotoxic challenges of colistimethate sodium through a preclinical study
by: Raktham Mektrirat, et al.
Published: (2023-11-01)

Macronutrient status and indicators of acid-alkaline blood balance in cats with chronic renal failure
by: V. I. Holovakha, et al.
Published: (2020-05-01)

Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania
by: Martin Sebastian Winkler, et al.
Published: (2023-11-01)

Relationship between FGF 23, SDMA, Urea, Creatinine and Phosphate in Relation to Feline Chronic Kidney Disease
by: Simona Grelová, et al.
Published: (2022-08-01)

Vincristine sulfate treatment influence on kidney function of female dogs with transmissible venereal tumor
by: Jessyca Vanderlei de Albuquerque Souza, et al.
Published: (2022-04-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy
by: Özgür Günebakmaz, et al.
Published: (2013-10-01)

Protein Arginine Methylation Patterns in Plasma Small Extracellular Vesicles Are Altered in Patients with Early-Stage Pancreatic Ductal Adenocarcinoma
by: Kritisha Bhandari, et al.
Published: (2024-02-01)

Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
by: Laszlo Zavori, et al.
Published: (2023-02-01)

Evaluation of kidney injury through early markers in canine pyometra
by: Andrezza Cavalcanti de Andrade, et al.
Published: (2023-05-01)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
by: Alice Savarese, et al.
Published: (2018-08-01)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
by: Laura Dowsett, et al.
Published: (2020-09-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)